Temperature is the strongest single driver of peptide decay in most workflows. These answers explain how PeptideClock handles temperature context without overstating certainty where peptide-specific assays are missing.
Higher temperatures usually accelerate chemical degradation pathways such as hydrolysis, oxidation, and aggregation. That means a peptide stored warm can lose potency much faster than the same peptide kept cold.
Not always. The answer depends on the peptide, the duration, and the formulation evidence. But room-temperature exposure should always be treated as a meaningful stability event, not ignored.
No. Refrigeration slows degradation but does not stop it. Potency still declines over time, and contamination or handling errors can still force a discard decision.
Freeze-thaw cycles can shift pH, concentrate solutes, and create aggregation stress. Some products are explicitly labeled do-not-freeze, while many research peptides are handled conservatively because peptide-specific freeze-thaw assay data is limited.
Baseline regulatory framework for temperature-driven stability testing.
Supports temperature-acceleration logic in pharmaceutical stability modeling.
Supports caution around non-linear aggregation behavior in biological systems.